Pin Oak Investment Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-133
Closed -$11K 475
2025
Q1
$11K Hold
133
0.01% 319
2024
Q4
$12K Hold
133
0.01% 322
2024
Q3
$11K Hold
133
0.01% 335
2024
Q2
$11K Hold
133
0.01% 325
2024
Q1
$11K Hold
133
0.01% 323
2023
Q4
$10K Hold
133
0.01% 335
2023
Q3
$10K Hold
133
0.01% 324
2023
Q2
$10K Hold
133
0.01% 325
2023
Q1
$10K Hold
133
0.01% 312
2022
Q4
$10K Sell
133
-133
-50% -$10.2K 0.01% 293
2022
Q3
$19K Hold
266
0.02% 221
2022
Q2
$20K Hold
266
0.02% 238
2022
Q1
$21K Hold
266
0.02% 256
2021
Q4
$22K Hold
266
0.02% 253
2021
Q3
$21K Hold
266
0.02% 250
2021
Q2
$21K Hold
266
0.02% 242
2021
Q1
$21K Hold
266
0.02% 247
2020
Q4
$19K Hold
266
0.02% 272
2020
Q3
$17K Hold
266
0.02% 262
2020
Q2
$17K Hold
266
0.02% 241
2020
Q1
$15K Hold
266
0.02% 246
2019
Q4
$17K Hold
266
0.01% 275
2019
Q3
$15K Hold
266
0.01% 286
2019
Q2
$16K Hold
266
0.01% 298
2019
Q1
$17K Hold
266
0.01% 276
2018
Q4
$19K Buy
+266
New +$18K 0.02% 250

Other funds holding PJP

Pin Oak Investment Advisors's PJP Position: Q2 2025 in Review

Pin Oak Investment Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2025, closing a stake of 133 shares — an estimated $11K sold.

Pin Oak Investment Advisors first reported a position in PJP in Q4 2018 and held it in 26 quarters. The position peaked at $22K in Q4 2021. 92 funds tracked by Wall St. Rank hold PJP as of Q2 2025.

  • Pin Oak Investment Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2025 after selling out during the quarter.
  • Pin Oak Investment Advisors sold 133 Invesco Pharmaceuticals ETF shares in Q2 2025, an estimated $11K.
  • Pin Oak Investment Advisors first reported a position in Invesco Pharmaceuticals ETF in Q4 2018 and held it in 26 quarters.
  • Pin Oak Investment Advisors's Invesco Pharmaceuticals ETF position peaked at $22K in Q4 2021.
  • 92 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2025.

Based on Pin Oak Investment Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.